glp 1 agonists drugs Glucagon-like peptide receptor (GLP-1 RAs): summary of Hype Or Hope? Latest Research

Since type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimers disease (AD) and both have the same pathogenesis (e.g., insulin resistance), drugs used to treat T2DM have been gradually found to reduce the progression of AD in AD models

Read more

The advent of incretin mimetics such as glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has enriched the armamentarium for diabetes management owing to their glycaemic as well as extra-glycaemic benefits

Codeage GLP-1 Probiotic+ is manufactured in the USA with global ingredients in a cGMP-certified facility

HbA1c and weight cohorts were analysed separately using an ANCOVA model